4//SEC Filing
KERYX BIOPHARMACEUTICALS INC 4
Accession 0000899243-17-011264
CIK 0001114220operating
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 4:05 PM ET
Size
5.1 KB
Accession
0000899243-17-011264
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Sale
Common Stock
2017-04-28$5.89/sh−1,219$7,180→ 146,404 total
Footnotes (2)
- [F1]Sale of a total of 1,219 shares of common stock was made in order to satisfy Mr. Holmes' income tax withholding obligation upon the vesting of 3,750 shares of restricted stock on April 27, 2017. Mr. Holmes had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 103,330 shares of restricted stock.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001114220
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 4:05 PM ET
- Size
- 5.1 KB